menu
    • menu

    Company profile for Neomorph

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neomorph is a venture-backed biotechnology company that focuses on addressing critical challenges in human health by discovering and developing innovative medicines targeting 'undruggable targets.' The company's team consists of industry-leading experts in protein degradation and molecular glues, known for their groundbreaking discoveries in the field. Neomorph is dedicated to leadership in advancing the science and technology...
    Neomorph is a venture-backed biotechnology company that focuses on addressing critical challenges in human health by discovering and developing innovative medicines targeting 'undruggable targets.' The company's team consists of industry-leading experts in protein degradation and molecular glues, known for their groundbreaking discoveries in the field. Neomorph is dedicated to leadership in advancing the science and technology of molecular glue drug discovery. Simultaneously, the company is actively progressing a pipeline of projects through clinical development, aiming to bring transformative therapies to the forefront of healthcare.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeomorphUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Diego, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neomorph.com/index.html#home
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xyramedical/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neomorph Initiates NEO-811 Trial For Advanced Kidney Cancer
    Neomorph Initiates NEO-811 Trial For Advanced Kidney Cancer

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231475/0/en/Neomorph-Announces-First-Patient-Dosed-in-Phase-1-2-Trial-Evaluating-NEO-811-For-the-Treatment-of-Locally-Advanced-or-Metastatic-Non-Resectable-Clear-Cell-Renal-Cell-Carcinoma.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    AbbVie crafts $1.6B deal with molecular glue biotech Neomorph
    AbbVie crafts $1.6B deal with molecular glue biotech Neomorph

    24 Jan 2025

    // PRESS RELEASE

    https://news.abbvie.com/2025-01-23-AbbVie-and-Neomorph-Announce-Collaboration-to-Develop-Molecular-Glue-Degraders-for-Oncology-and-Immunology

    PRESS RELEASE
    24 Jan 2025
    Share Share
    Neomorph Appoints Klaus Wagner As Chief Medical Officer
    Neomorph Appoints Klaus Wagner As Chief Medical Officer

    14 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neomorph-announces-appointment-of-dr-klaus-wagner-md-phd-as-chief-medical-officer-302350211.html

    PR NEWSWIRE
    14 Jan 2025
    Share Share
    Biogen and Neomorph Collaborate on Molecular Glue Degraders
    Biogen and Neomorph Collaborate on Molecular Glue Degraders

    29 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/29/2971307/0/en/Biogen-and-Neomorph-Announce-Multi-Target-Research-Collaboration-to-Discover-and-Develop-Molecular-Glue-Degraders-for-Alzheimer-s-Rare-and-Immunological-Diseases.html

    GLOBENEWSWIRE
    29 Oct 2024
    Share Share
    Neomorph Appoints Dr. Peter Lebowitz To Board Of Directors
    Neomorph Appoints Dr. Peter Lebowitz To Board Of Directors

    20 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neomorph-announces-appointment-of-dr-peter-lebowitz-md-phd-to-its-board-of-directors-302225853.html

    PR NEWSWIRE
    20 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search